PT-141 (Bremelanotide)
Aprovado pela FDA para transtorno de excitação sexual feminina
Visão Geral
PT-141 (Bremelanotide) é um agonista do receptor de melanocortina aprovado pela FDA para o tratamento do transtorno do desejo sexual hipoativo (TDSH) em mulheres na pré-menopausa.
Key Information
Mecanismo
Ativa os receptores de melanocortina no cérebro, especificamente o MC4R, para aumentar o desejo sexual de forma independente do sistema vascular.
Benefits
- Aumento do desejo sexual
- Aprovado pela FDA para TDSH (transtorno do desejo sexual hipoativo)
- Ação mediada pelo cérebro (não vascular)
- Uso sob demanda
Side Effects
- Náusea (40%)
- Ruborização
- Dor de cabeça
- Escurecimento da pele
Contraindications
- Cardiovascular disease
- Pregnancy
Evidence Summary
Aprovado pela FDA com base em ensaios de Fase 3 para o transtorno do desejo sexual hipoativo.
Research
Aprovado pela FDA como Vyleesi com base em estudos de Fase 3 que demonstraram melhora significativa no desejo sexual e no sofrimento associado.
Ver InvestigaciónSafety
Aprovado pela FDA. Efeitos colaterais: náusea, rubor, dor de cabeça.
Frequently Asked Questions About PT-141 (Bremelanotide)
What is PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) is a research peptide also known as Bremelanotide; Vyleesi. Aprovado pela FDA para transtorno de excitação sexual feminina It is studied for its potential therapeutic applications and is available from various research chemical vendors.
How does PT-141 (Bremelanotide) work?
Ativa os receptores de melanocortina no cérebro, especificamente o MC4R, para aumentar o desejo sexual de forma independente do sistema vascular.
What is the recommended dosage for PT-141 (Bremelanotide)?
The commonly studied dosage range for PT-141 (Bremelanotide) is 1.75 mg as needed. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. PT-141 (Bremelanotide) should only be used in controlled research settings.
Where can I buy PT-141 (Bremelanotide)?
PepsReview indexes PT-141 (Bremelanotide) pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.
Is PT-141 (Bremelanotide) legal?
US regulatory status: FDA-approved (Vyleesi). The legal status of PT-141 (Bremelanotide) varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.
What are the side effects of PT-141 (Bremelanotide)?
Reported side effects include: Náusea (40%), Ruborização, Dor de cabeça, Escurecimento da pele. Always review safety data and published studies before use.
Key Research Papers on PT-141 (Bremelanotide)
The following peer-reviewed studies and clinical trials are indexed in our research library for PT-141 (Bremelanotide). Each paper links to a detailed summary with key findings, study design, and publication metadata.
- PT-141 Palatin — Curr Opin Investig Drugs, 2004 (440 citations)
- An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist — J Sex Med, 2006 (400 citations)
- Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder — Ann Pharmacother, 2020 (120 citations)
- Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment — J Midwifery Womens Health, 2021 (100 citations)
- Bremelanotide for Treatment of Female Hypoactive Sexual Desire — Neurol Int, 2022 (80 citations)
Write a Review
Login to write a review
You need an account to share your experience with PT-141 (Bremelanotide).
CadastrarRating Breakdown
Based on 2 avaliações.
Avaliações
PT-141 (bremelanotide) restored my libido completely. The fact it's FDA-approved for HSDD is a major plus. Brain-mediated mechanism is different from vascular drugs - works on desire not just blood flow. On-demand use is convenient.
PT-141 takes about 2 hours to kick in. The desire increase is real - not just physical. Nausea is the main side effect. FDA approval makes me feel safe. Better than PDE5 inhibitors for psychological ED.